Flibanserin for female sexual dysfunction

Drugs of Today

Volumn 50, Issue 8, 2014, Pages 549-556

  Reviriego, C ^a  

^a NONE   (United Kingdom)

Author keywords

BIMT 17; Flibanserin; Hypoactive sexual desire disorder (HSDD); Serotonin 5 HT1Areceptor agonist; Serotonin 5 HT2Areceptor antagonist

Indexed keywords

ACETYLSALICYLIC ACID; DOPAMINE; FLIBANSERIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; BENZIMIDAZOLE DERIVATIVE; SEROTONIN;

ARTICLE; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; LIBIDO; NAUSEA; POSTMENOPAUSE; PREMENOPAUSE; SEXUAL SATISFACTION; SOMNOLENCE; BIMT-17; DRUG EFFECT; HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD); METABOLISM; PSYCHOSEXUAL DISORDER; SEROTONIN 5-HT1A RECEPTOR AGONIST; SEROTONIN 5-HT2A RECEPTOR ANTAGONIST;

BIMT-17; FLIBANSERIN; HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD); SEROTONIN 5-HT1A RECEPTOR AGONIST; SEROTONIN 5-HT2A RECEPTOR ANTAGONIST;

BENZIMIDAZOLES; DOPAMINE; FEMALE; HUMANS; LIBIDO; NOREPINEPHRINE; PREMENOPAUSE; SEROTONIN; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84907172425     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2014.50.8.2198036     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. American Psychiatric Press: Washington, D.C., 2000.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 2nd Edition. American Psychiatric Press: Washington, D.C., 1968.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. American Psychiatric Press: Washington, D.C., 1987.
4. Leiblum, S.R., Koochaki, P.E., Rodenberg, C.A., Barton, I.P., Rosen, R.C. Hypoactive sexual desire disorder in postmenopausal women. US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006, 13(1): 46-56.
5. Dennerstein, L., Koochaki, P., Barton, I., Graziottin, A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 2006, 3(2): 212-22.
6. Shifren, J.L., Monz, B.U., Russo, P.A., Segreti, A., Johannes, C.B. Sexual problems and distress in United States women. Prevalence and correlates. Obstet Gynecol 2008, 112(5): 970-8.
7. West, S.L., D'Aloisio, A.A., Agans, R.P., Kalsbeek, W.D., Borisov, N.N., Thorp, J.M. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representa- tive sample of US women. Arch Intern Med 2008, 168(13): 1441-9.
8. Trudel, G., Marchand, A., Ravart, M., Aubin, S., Turgeon, L., Fortier, P. The effect of a cognitive-behavioral treatment program on hypoactive sexual desire in women. Sex Relat Ther 2001, 16(2): 145-64.
9. Palacios, S. Hypoactive sexual desire disorder and current pharmacotherapeutic options in women. Women's Health (Lond Engl) 2011, 7(1): 95-107.
10. Braunstein, G.D., Sundwall, D.A., Katz, M. et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005, 165(14): 1582-9.
11. Panay, N., Al-Azzawi, F., Bouchard, C. et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 2010, 13(2): 121-31.
12. Davis, S.R., Moreau, M., Kroll, R. et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008, 359(19): 2005-17.
13. Cummings, S.R., Ettinger, B., Delmas, P.D. et al. The effects of tibolone in older postmenopausal women. N Engl J Med 2008, 359(7): 697-708.
14. Davis, S.R., Panjari, M., Stanczyk, F.Z. Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011, 96(6): 1642-53.
15. Stahl, S.M., Sommer, B., Allers, K.A. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med 2011, 8(1): 15-27.
16. Invernizzi, R.W., Sacchetti, G., Parini, S., Acconcia, S., Samanin, R. Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: Role of 5-HT1A receptors. Br J Pharmacol 2003, 139(7): 1281-8.
17. Borsini, F. BIMT 17: A putative fast acting antidepressant. Eur Neuropsychopharmacol 1996, 6(Suppl. 4): Abst S.10.03.
18. D'Aquila, P., Monleon, S., Borsini, F., Brain, P., Willner, P. Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant. Eur J Pharmacol 1997, 340(2-3): 121-32.
19. Pyke, R., Cotton, D., Kennedy, S., Lewis-D'Agostino, D.J. Flibanserin: A novel centrally acting agent that is not an effective antidepressant but has potential to treat decreased sexual desire in women. 161st Annu Meet Am Psychiatr Assoc (May 3-8, Washington, D.C.) 2008, Abst NR5-119.
20. Kennedy, S. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder. J Sex Med 2010, 7(10): 3449-59.
21. Lenzer, J. Boehringer Ingelheim withdraws libido drug for women. BMJ 2010, 341: c5701.
22. Moynihan, R. Drug for low sexual desire carries significant harms, FDA advisers. BMJ 2010, 341: c3339.
23. Sprout Pharmaceuticals confirms resubmission to FDA of flibanserin for treatment of pre-menopausal hypoactive sexual desire disorder [news release]. Sprout Pharmaceuticals, Inc., June 26, 2013.
24. Sprout Pharmaceuticals receives clear guidance from FDA on path forward to resubmit New Drug Application for flibanserin, the first potential medical treatment for hypoactive sexual desire disorder in premenopausal women [news release]. Sprout Pharmaceuticals, Inc., February 11, 2014.
25. Ferger, B., Shimasaki, M., Ceci, A., Ittrich, C., Allers, K.A., Sommer, B. Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats. Naunyn-Schmied Arch Pharmacol 2010, 381(6): 573-9.
26. Troconiz, I.F., Boland, K., Staab, A. Population pharmacokinetic/ pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers. Pharm Res 2012, 29(6): 1518-29.
27. Boehringer Ingelheim. Briefing document, Flibanserin Tablet, NDA 22-526 Reproductive Health Drugs Advisory Committee Meeting, June 18, 2010. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/Co mmitteesMeetingMaterials/Drugs/ReproductiveHealthDr ugsAdvisoryCommittee/UCM215438.pdf.
28. Lippert, J., Boland, K., Willmann, S. et al. Stimulation of pharmacokinetics of flibanserin under itraconazole co-medication with and integrated physiologically-based pharmacokinetic model. Annu Meet Population Approach Group Eur (PAGE) (June 8-11, Berlin) 2010, Abst 1871.
29. Ferger, B., Shimasaki, M., Ceci, A., Allers, K., Sommer, B. Neurochemical characterization of Flibanserin a phase III drug for treatment of Hypoactive Sexual Desire Disorder (HSDD) in women. 39th Annu Meet Soc Neurosci (October 17-21, Chicago) 2009, Abst 465.18.
30. Allers, K.A., Dremencov, E., Ceci, A. et al. Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study. J Sex Med 2010, 7(5): 1757-67.
31. Thorp, J., Simon, J., Dattani, D. et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med 2012, 9(3): 793-804.
32. Derogatis, L.R., Komer, L., Katz, M. et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study. J Sex Med 2012, 9(4): 1074-85.
33. Goldfischer, E.R., Breaux, J., Katz, M. et al. Efficacy and safety of flibanserin in a randomized withdrawal study of premenopausal women with hypoactive sexual desire disorder. 19th World Congr Sex Health (June 21-25, Göteborg) 2009, Abst OP1.1-2.
34. Pyke, R., Goldfischer, E., Mikl, J. Safety and tolerability of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): Results from the ROSE study. 161st Annu Meet Am Psychiatr Assoc (May 3-8, Washington, D.C.) 2008, Abst NR5-118.
35. Jayne, C., Simon, J., Taylor, L., Kimura, T., Pyke, R., Lesko, L. A 12-month, open-label trial of flibanserin in North American women with generalized acquired hypoactive sexual desire disorder (HSDD): The sunflower trial. Fertil Steril [66th Annu Meet Am Soc Reprod Med (ASRM) (October 23-27, Denver) 2010] 2010, 94(4): Abst O-45.
36. Clayton, A.H., Jolly, E., Thorp, J., Lewis D'Agostino, D., Wunderlich, G., Lesko, L.M. Baseline characteristics of patients enrolled in three phase III North American trials of flibanserin in premenopausal women with hypoactive sexual desire disorder. 19th World Congr Sex Health (June 21-25, Göteborg) 2009, Abst MP5-4.
37. Goldfischer, E.R., Breaux, J., Katz, M. et al. Efficacy of continued flibanserin treatment in premenopausal women with hypoactive sexual desire disorder: Results from the ROSE study. Jt Cong Eur Int Soc Sex Med (December 7-11, Brussels) 2008, Abst PD-002.
38. Simon, J.A., Thorp, J.M., Katz, M., Pyke, R. Onset of efficacy of flibanserin in premenopausal women with hypoactive sexual desire disorder. 58th Annu Clin Meet Am Coll Obstet Gynecologists (May 15-19, San Francisco) 2010, Abst.
39. Clayton, A.H., Katz, M., Simon, J.A., Sand, M. Efficacy of flibanserin in premenopausal women with hypoactive sexual desire disorder: Remitter analyses. 58th Annu Clin Meet Am Coll Obstet Gynecologists (May 15-19, San Francisco) 2010, Abst 119.
40. Krychman, M.L., Kingsburg, S., Jolly, E., Hoppe, D., Sands, M. Efficacy of the use of flibanserin, 100 mg qhs, in premenopausal women with hypoactive sexual desire disorder: Sexual satisfaction. 58th Annu Clin Meet Am Coll Obstet Gynecologists (May 15-19, San Francisco) 2010, Abst.
41. Jolly, E.E., Thorp, J.M., Clayton, A.H., Kimura, T., Pyke, R. Patients' perspective of efficacy of flibanserin in the treatment of premenopausal women with hypoactive sexual desire disorder. 58th Annu Clin Meet Am Coll Obstet Gynecologists (May 15-19, San Francisco) 2010, Abst.
42. Katz, M., DeRogatis, L.R., Ackerman, R., Hedges, P., Lesko, L., Garcia, M., Sand, M. Efficacy of flibanserin in women with Hypoactive Sexual Desire Disorder: Results from the BEGONIA trial. J Sex Med 2013, 10(7): 1807-15.